<p><strong>施瓦布美国股息股票 ETF</strong> (NYSEARCA:SCHD) 在追求收益的投资者中享有盛誉，因其兼具质量和收益。该 ETF 提供 4.14% 的股息收益率，这是你能在热门 ETF 中获得的最高收益之一。它的费用比率也相当低，仅为 0.06%。其投资组合专注于家喻户晓的品牌，并且分散投资良好，因此即使股市下跌，这里也不太可能遭受太大损失。</p>
<ul>
<li>如果你喜欢 SCHD ETF，这些个股值得更多关注。</li>
</ul>
<ul>
<li>这些股票提供稳健的股息和安全性，就像 SCHD ETF 一样。</li>
</ul>
<ul>
<li>这里的股息也高于国债收益率。</li>
</ul>
<ul>
<li>你在退休方面是领先还是落后？SmartAsset 的免费工具可以在几分钟内将你与财务顾问匹配，帮助你今天回答这个问题。每位顾问都经过严格筛选，必须以你的最佳利益为重。不要再浪费时间；点击这里开始吧。(赞助商)</li>
</ul>
<p>没有任何 ETF 是完美的。市场上有一些个股的收益率更高且安全性良好。这些股票虽然无法提供多样化，但将它们纳入你的投资组合仍然是值得的。精心挑选的高收益股票在国债收益率不可避免地下降时，可能会带来稳健的长期回报，吸引更多投资者将资金投入股息股票。</p>
<h2><strong>威瑞森通信 (VZ)</strong></h2>
<p>SCHD ETF 持有 <strong>威瑞森通信</strong> (NYSE:VZ)，但我认为增加对这只股票的投资是个不错的主意。如果你一直关注通信行业，你可能已经注意到 <strong>AT&amp;T</strong> (NYSE:T) 在过去几个月表现出色，已经完全从多年的抛售中恢复过来。在这里买入的投资者正在获得丰厚的回报，不仅收获了可观的股息，还享受到了显著的上涨。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>威瑞森未来也可能带来类似的上涨。威瑞森以更高的收入潜力补充了 ETF 的稳定性，并在美国无线市场占据主导地位。这是一家稳健的公司，在这些水平上不太可能让你失望。即使真的失望，也很可能是短期的。</p>
<p>这里的吸引力不仅仅在于丰厚的股息支票，公司正处于增长复兴的过程中，新增用户激增。威瑞森在 2024 年第四季度新增了近一百万用户。这是五年来的最佳增长。</p>
<p>因此，威瑞森在 2024 年实现了 1348 亿美元的营业收入。仅无线业务就占其中的 200 亿美元。每股收益也从前一年的 2.75 美元攀升至 4.14 美元。</p>
<p>公司的管理层现在预计，由于定价能力和客户升级，其无线服务收入将在今年增长 2-2.8%。它正在通过收购 <strong>边疆通信</strong> (NASDAQ:FYBR) 来增强其宽带覆盖，并且还在投资于人工智能和 5G。VZ 目前的股息收益率为 6.1%，并连续 20 年增加股息。</p>
<h2><strong>英美烟草 (BTI)</strong></h2>
<p><strong>英美烟草</strong> (NYSE:BTI) 不应被忽视，因为烟草公司在应对吸烟率下降方面表现得相当不错。BTI 股票在过去一年上涨了 48.2%，并且已经完全从 2022-2023 年的抛售中恢复过来，甚至有所上升。该股票在过去五年中上涨了 13%。它正在转向无烟产品，并计划到 2035 年将 50% 的收入来自非燃烧产品。</p>
<p>与此同时，财务状况良好。它报告了 2024 年全年的收入为 259 亿英镑，净收入为 32 亿英镑。现在它是全球第二大烟草公司，按净销售额计算。</p>
<p>我现在喜欢烟草公司的一个原因是，它们在经济衰退中具有抗风险能力，并且提供稳健的股息。显而易见，这些公司的需求在经济环境变化时往往是无弹性的。烟草并不是人们预算中的大头，反而在经济衰退期间，人们的消费可能会增加，而不是减少。</p>
<p>BTI 股票现在的收益率超过 7%，而 62.37% 的派息比率也为未来的加息留出了空间。</p>
<h2><strong>辉瑞 (PFE)</strong></h2>
<p><strong>辉瑞</strong> (NYSE:PFE) 是一家在许多圈子里声誉不佳的公司，但许多人忘记了这家公司并非单一业务。它生产的不仅仅是 COVID 疫苗，尽管这些疫苗不再推动经常性收入，但它还有许多其他产品来弥补这一点，并保持每年支付稳健的股息。</p>
<p>最近，辉瑞因放弃其减肥药而登上头条。该股票也下跌了 14.2%，但我实际上会利用这种负面情绪作为在低点买入的理由。这里的股息收益率目前为 7.7%。这些股息不太可能在短期内消失，因为辉瑞已经连续 16 年提高股息。派息比率也为 56.98%，因此它可以继续增加股息。</p>
<p>这里的财务基础稳固。辉瑞已重申其 2025 年的收入指引，预计在 610 亿到 640 亿美元之间，调整后的每股收益预计将上升至 2.8 到 3 美元。此外，该公司在去年年底实现了 40 亿美元的净节省，并计划在今年再节省 5 亿美元。</p>
<p>你有一家精简的公司，专注于推动研发生产力，预计在 2025 年将有多个晚期结果和监管决策，这可能会产生下一代的重磅药物。我会在低点买入并收集这些股息。</p>
<p>共识目标价暗示 39% 的上涨空间。</p>
<p>如果你喜欢施瓦布的 SCHD，你绝对不能错过这些收益更高的股票。文章首发于 24/7 Wall St..</p>

英美烟草

威瑞森

<p>施瓦布美国股息股票 ETF（SCHD）受到以收入为导向的投资者青睐，因其 4.14% 的收益率和低费用比率。然而，像威瑞森（6.1% 收益率）和英美烟草（超过 7% 收益率）这样的个股提供了更高的股息。威瑞森在新用户增长和强劲的无线业务方面表现良好，而英美烟草则正在转向无烟产品，并且在经济衰退中依然具有抗风险能力。这两只股票都提供了稳健的收入潜力，可以增强以股息为重点的投资组合</p>

<p><strong>The Schwab U.S. Dividend Equity ETF</strong> (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors who want both quality and yield. The ETF offers a 4.14% dividend yield, and this is one of the highest yields you can get with a popular ETF. It is also quite cost-effective with a low expense ratio of 0.06%. Its portfolio focuses on household names and is well-diversified, so even a stock market downturn is unlikely to cause too much pain here.</p>
<div class="lb-trans"><p><strong>施瓦布美国股息股票 ETF</strong> (NYSEARCA:SCHD) 在追求收益的投资者中享有盛誉，因其兼具质量和收益。该 ETF 提供 4.14% 的股息收益率，这是你能在热门 ETF 中获得的最高收益之一。它的费用比率也相当低，仅为 0.06%。其投资组合专注于家喻户晓的品牌，并且分散投资良好，因此即使股市下跌，这里也不太可能遭受太大损失。</p>
</div><ul>
<li>If you like the SCHD ETF, these individual stocks are worth having more exposure to.</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你喜欢 SCHD ETF，这些个股值得更多关注。</li>
</ul>
</div><ul>
<li>These stocks give you solid dividends and safety, just like the SCHD ETF.</li>
</ul>
<div class="lb-trans"><ul>
<li>这些股票提供稳健的股息和安全性，就像 SCHD ETF 一样。</li>
</ul>
</div><ul>
<li>The dividends here are also higher than the Treasury yield.</li>
</ul>
<div class="lb-trans"><ul>
<li>这里的股息也高于国债收益率。</li>
</ul>
</div><ul>
<li>Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor)</li>
</ul>
<div class="lb-trans"><ul>
<li>你在退休方面是领先还是落后？SmartAsset 的免费工具可以在几分钟内将你与财务顾问匹配，帮助你今天回答这个问题。每位顾问都经过严格筛选，必须以你的最佳利益为重。不要再浪费时间；点击这里开始吧。(赞助商)</li>
</ul>
</div><p>No ETF is perfect. There are individual stocks with higher yields and solid safety. These stocks aren’t going to give you the diversification, but having them in your portfolio is still worth it. Hand-picked high-yield stocks could deliver solid long-term returns as Treasury yields inevitably come down and more investors park their money in dividend stocks.</p>
<div class="lb-trans"><p>没有任何 ETF 是完美的。市场上有一些个股的收益率更高且安全性良好。这些股票虽然无法提供多样化，但将它们纳入你的投资组合仍然是值得的。精心挑选的高收益股票在国债收益率不可避免地下降时，可能会带来稳健的长期回报，吸引更多投资者将资金投入股息股票。</p>
</div><h2><strong>Verizon Communications (VZ)</strong></h2>
<div class="lb-trans"><h2><strong>威瑞森通信 (VZ)</strong></h2>
</div><p>The SCHD ETF holds <strong>Verizon Communications</strong> (NYSE:VZ), but I think more exposure to this stock is a solid idea. If you’ve been watching the communications sector, you’re likely aware that <strong>AT&amp;T</strong> (NYSE:T) has made a stellar comeback over the past few months and has fully recovered from a multi-year selloff. Investors who bought the dip here are raking in the dough, as not only have they collected solid dividends, they’ve also been rewarded with solid upside.</p>
<div class="lb-trans"><p>SCHD ETF 持有 <strong>威瑞森通信</strong> (NYSE:VZ)，但我认为增加对这只股票的投资是个不错的主意。如果你一直关注通信行业，你可能已经注意到 <strong>AT&amp;T</strong> (NYSE:T) 在过去几个月表现出色，已经完全从多年的抛售中恢复过来。在这里买入的投资者正在获得丰厚的回报，不仅收获了可观的股息，还享受到了显著的上涨。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>Verizon could deliver a similar upside going forward. Verizon complements the ETF’s stability with higher income potential and has a dominant position in the U.S. wireless market. This is a sturdy company that is unlikely to disappoint you at these levels. And even if it does, it’s likely to be short-term.</p>
<div class="lb-trans"><p>威瑞森未来也可能带来类似的上涨。威瑞森以更高的收入潜力补充了 ETF 的稳定性，并在美国无线市场占据主导地位。这是一家稳健的公司，在这些水平上不太可能让你失望。即使真的失望，也很可能是短期的。</p>
</div><p>The appeal here goes beyond just a fat dividend check, and the company is in the midst of a growth renaissance with a surge in subscriber additions. Verizon has added nearly a million new subscribers in Q4 2024. This is the best growth in five years.</p>
<div class="lb-trans"><p>这里的吸引力不仅仅在于丰厚的股息支票，公司正处于增长复兴的过程中，新增用户激增。威瑞森在 2024 年第四季度新增了近一百万用户。这是五年来的最佳增长。</p>
</div><p>As a result, Verizon posted operating revenues of $134.8 billion in 2024. The wireless segment alone constituted $20 billion of that. EPS also climbed to $4.14 from $2.75 the year before.</p>
<div class="lb-trans"><p>因此，威瑞森在 2024 年实现了 1348 亿美元的营业收入。仅无线业务就占其中的 200 亿美元。每股收益也从前一年的 2.75 美元攀升至 4.14 美元。</p>
</div><p>The company’s management now projects that its wireless service revenue will grow 2-2.8% this year due to more pricing power and customer upgrades. It is future-proofing its business with a pending acquisition of <strong>Frontier Communications</strong> (NASDAQ:FYBR) to boost its broadband reach and is also investing in AI and 5G. VZ currently has a 6.1% dividend yield with 20 consecutive years of dividend increases.</p>
<div class="lb-trans"><p>公司的管理层现在预计，由于定价能力和客户升级，其无线服务收入将在今年增长 2-2.8%。它正在通过收购 <strong>边疆通信</strong> (NASDAQ:FYBR) 来增强其宽带覆盖，并且还在投资于人工智能和 5G。VZ 目前的股息收益率为 6.1%，并连续 20 年增加股息。</p>
</div><h2><strong>British American Tobacco (BTI)</strong></h2>
<div class="lb-trans"><h2><strong>英美烟草 (BTI)</strong></h2>
</div><p><strong>British American Tobacco</strong> (NYSE:BTI) shouldn’t be left out of the equation, as tobacco companies have done surprisingly well to grapple with declining smoking rates. BTI stock is up 48.2% in the past year and has completely recovered from the 2022-2023 selloffs and then some. The stock is now up 13% in the past five years. It is shifting to smokeless products and aims to derive 50% of its revenue from non-combustibles by 2035.</p>
<div class="lb-trans"><p><strong>英美烟草</strong> (NYSE:BTI) 不应被忽视，因为烟草公司在应对吸烟率下降方面表现得相当不错。BTI 股票在过去一年上涨了 48.2%，并且已经完全从 2022-2023 年的抛售中恢复过来，甚至有所上升。该股票在过去五年中上涨了 13%。它正在转向无烟产品，并计划到 2035 年将 50% 的收入来自非燃烧产品。</p>
</div><p>In the meantime, the financials have been solid. It reported full-year 2024 revenue of GBP 25.9 billion and net income of GBP 3.2 billion. This is now the world’s second-largest tobacco company by net sales.</p>
<div class="lb-trans"><p>与此同时，财务状况良好。它报告了 2024 年全年的收入为 259 亿英镑，净收入为 32 亿英镑。现在它是全球第二大烟草公司，按净销售额计算。</p>
</div><p>One thing that I like about tobacco companies now is that they come with recession resistance alongside solid dividends. For obvious reasons, these companies tend to have inelastic demand regardless of the economic climate. Tobacco is not a big portion of people’s budgets, and if anything, people will consume more, not less, during a recession.</p>
<div class="lb-trans"><p>我现在喜欢烟草公司的一个原因是，它们在经济衰退中具有抗风险能力，并且提供稳健的股息。显而易见，这些公司的需求在经济环境变化时往往是无弹性的。烟草并不是人们预算中的大头，反而在经济衰退期间，人们的消费可能会增加，而不是减少。</p>
</div><p>BTI stock now yields over 7%, and while the payout ratio of 62.37% also leaves room for more hikes down the line.</p>
<div class="lb-trans"><p>BTI 股票现在的收益率超过 7%，而 62.37% 的派息比率也为未来的加息留出了空间。</p>
</div><h2><strong>Pfizer (PFE)</strong></h2>
<div class="lb-trans"><h2><strong>辉瑞 (PFE)</strong></h2>
</div><p><strong>Pfizer</strong> (NYSE:PFE) is a company that doesn’t have the best reputation in many circles, but many people forget that this company is not a one-trick pony. It makes more than COVID vaccines, and even though those vaccines are no longer driving recurring revenue, it has plenty of other products to offset that and keep paying solid dividends year after year.</p>
<div class="lb-trans"><p><strong>辉瑞</strong> (NYSE:PFE) 是一家在许多圈子里声誉不佳的公司，但许多人忘记了这家公司并非单一业务。它生产的不仅仅是 COVID 疫苗，尽管这些疫苗不再推动经常性收入，但它还有许多其他产品来弥补这一点，并保持每年支付稳健的股息。</p>
</div><p>Recently, Pfizer has been in the headlines for letting go of its weight loss pill. The stock is also down 14.2%, but I’d actually use the negativity as an excuse to buy it on the dip. The dividend yield here is a stellar 7.7% right now. These dividends are unlikely to go away anytime soon, as Pfizer has hiked these dividends for 16 consecutive years. The payout ratio is also at 56.98%, so it could keep increasing dividends.</p>
<div class="lb-trans"><p>最近，辉瑞因放弃其减肥药而登上头条。该股票也下跌了 14.2%，但我实际上会利用这种负面情绪作为在低点买入的理由。这里的股息收益率目前为 7.7%。这些股息不太可能在短期内消失，因为辉瑞已经连续 16 年提高股息。派息比率也为 56.98%，因此它可以继续增加股息。</p>
</div><p>The financial footing here is solid. Pfizer has reaffirmed its revenue guidance for 2025 in the range of $61 to $64 billion, with adjusted earnings per share expected to rise to $2.8 to $3. Moreover, the company posted $4 billion in net savings by the end of last year and plans to save another $500 million this year.</p>
<div class="lb-trans"><p>这里的财务基础稳固。辉瑞已重申其 2025 年的收入指引，预计在 610 亿到 640 亿美元之间，调整后的每股收益预计将上升至 2.8 到 3 美元。此外，该公司在去年年底实现了 40 亿美元的净节省，并计划在今年再节省 5 亿美元。</p>
</div><p>You have a lean company that is keenly focused on driving R&amp;D productivity, with several late-stage readouts and regulatory decisions expected in 2025 that could yield the next generation of blockbuster medicines. I’d buy the dip and collect those dividends.</p>
<div class="lb-trans"><p>你有一家精简的公司，专注于推动研发生产力，预计在 2025 年将有多个晚期结果和监管决策，这可能会产生下一代的重磅药物。我会在低点买入并收集这些股息。</p>
</div><p>The consensus price target implies 39% upside.</p>
<div class="lb-trans"><p>共识目标价暗示 39% 的上涨空间。</p>
</div><p>The post If You Like Schwab’s SCHD, You Can’t Miss These Stocks With Even Higher Yields appeared first on 24/7 Wall St..</p>
<div class="lb-trans"><p>如果你喜欢施瓦布的 SCHD，你绝对不能错过这些收益更高的股票。文章首发于 24/7 Wall St..</p>
</div>

如果你喜欢施瓦布的 SCHD 基金，那么你一定不能错过这些收益率更高的股票